* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Human Genome Sciences

Phase Bioscience appoints Craig Rosen executive chairman

David Ranii, Staff Writer Comment on this story MORRISVILLE - Drug development company Phase Bioscience has named biotechnology industry heavy hitter Craig Rosen its executive chairman. Rosen, 50, is former president and chief...

BUYINS.NET: (ARE) SqueezeTrigger Price is $93.357. There is $345,790,509.00 That Short Sellers...

BUYINS.NET / www.squeezetrigger.com is monitoring ALEXANDRIA REAL EST EQTS INC (NYSE:ARE) in real time and just received an alert that is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start...

Biolex Raises $60M, Buys Rest of Locteron Rights from OctoPlus

Financings Roundup Biolex Therapeutics Inc. raised $60 million in a Series D financing to complete its ongoing Phase II program with Locteron, a controlled-release version of interferon alpha for hepatitis C. The Pittsboro...

Register for the Biotech 2008 Career Fair on November 11th

BioNJ and Pennsylvania Bio announce that the third annual Biotech 2008 Career Fair will be held on Tuesday, November 11, 2008, from 11:00 a.m. - 4:00 p.m. at the Loews Philadelphia Hotel in Philadelphia, PA. The Biotech 2008...

DIARY - U.S. Company Meetings for week ahead

REUTERS,Oct 06, 2008 - DATE GMT SYMBOL EVENT TITLE 06 Oct 12:30 A.D.A.M., Inc. at JMP Securities LLC Focus Conf 06 Oct 22:05 Abraxas at Independent Petroleum Asso. of America Conf 06 Oct 17:00 ACADIA Pharma.S INC at JMP...

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities...

Friday October 3, 8:00 am ET ROCKVILLE, Md., Oct. 3 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI - News) announced today that its presentation at the JMP Securities Healthcare Focus Conference will be...

Arana Completes Series Of Humanised And Improved Antibodies For Vegenics' Cancer Treatment Program

Antibody therapeutics company Arana Therapeutics Limited (ASX:AAH) and biologics drug development company Circadian Technologies Limited (ASX:CIR) today announced that Arana has successfully engineered an improved version of...

Human Genome Sciences Completes Enrollment In Second Phase 3 Lymphostat-B(R) Trial

Human Genome Sciences, Inc. (Nasdaq: HGSI) announced it has completed enrollment and initial dosing in BLISS-76, the second of two pivotal Phase 3 randomized clinical trials of LymphoStat-B® (belimumab) in patients with active...

BellwetherReport.com Analyst Opinions on HGSI, CA, TIBX and SCMR

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. TORONTO--(Marketwire - September 19, 2008) - BellwetherReport.com is the leading online financial newsletter for investors...

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference

ROCKVILLE, Md., Sept. 18 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. announced today that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at http://www.hgsi.com/...

1 2 3 4 5 next »